Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 17/20 | 0.80 |
| ▸ | DRD3 | P35462 | 4/20 | 0.80 |
| ▸ | HTR1A | P08908 | 3/20 | 0.80 |
| ▸ | HTR2A | P28223 | 3/20 | 0.80 |
| ▸ | HTR2B | P41595 | 3/20 | 0.80 |
| ▸ | DRD1 | P21728 | 2/20 | 0.80 |
| ▸ | DRD4 | P21917 | 2/20 | 0.80 |
| ▸ | DRD5 | P21918 | 2/20 | 0.80 |
| ▸ | HTR2C | P28335 | 2/20 | 0.80 |
| ▸ | HTR7 | P34969 | 2/20 | 0.80 |
| ▸ | HTR6 | P50406 | 2/20 | 0.80 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.80 |
| ▸ | MEN1 | O00255 | 1/20 | 0.80 |
| ▸ | MLNR | O43193 | 1/20 | 0.80 |
| ▸ | HTR3B | O95264 | 1/20 | 0.80 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.80 |
| ▸ | ESR1 | P03372 | 1/20 | 0.80 |
| ▸ | PGR | P06401 | 1/20 | 0.80 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.80 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2615305 | 0.91 | DRD2 (0.67) | DRD2DRD3HTR1AHTR2AHTR2B | |
| Aripiprazole SCHEMBL8255 | 0.89 | DRD2 (1.00) | DRD2DRD3HTR1AHTR2AHTR2B | |
| Aripiprazole SCHEMBL29475637 | 0.89 | DRD2 (1.00) | DRD2DRD3HTR1AHTR2AHTR2B | |
| Aripiprazole SCHEMBL982189 | 0.89 | DRD2 (1.00) | DRD2DRD3HTR1AHTR2AHTR2B | |
| Aripiprazole SCHEMBL29438823 | 0.89 | DRD2 (1.00) | DRD2DRD3HTR1AHTR2AHTR2B | |
| SCHEMBL7254171 | 0.89 | DRD2 (0.80) | DRD2DRD3HTR1AHTR2AHTR2B | |
| Aripiprazole SCHEMBL29475638 | 0.89 | DRD2 (1.00) | DRD2DRD3HTR1AHTR2AHTR2B | |
| Aripiprazole SCHEMBL29356997 | 0.89 | DRD2 (1.00) | DRD2DRD3HTR1AHTR2AHTR2B | |
| Aripiprazole SCHEMBL30958766 | 0.88 | DRD2 (0.98) | DRD2DRD3HTR1AHTR2AHTR2B | |
| Aripiprazole SCHEMBL31174198 | 0.88 | DRD2 (0.98) | DRD2DRD3HTR1AHTR2AHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9670200-B2 | Quaternary ammonium salt prodrugs | ALKERMES PHARMA IRELAND LIMITED (IE) | 2017-06-06 | — | — | US | disclosed |
| EP-2079723-B1 | PROCESS FOR PREPARING ANHYDROUS ARIPIPRAZOLE TYPE I | CAMBREX CHARLES CITY INC (US) | 2012-12-19 | — | — | EP | disclosed |
| US-20110178068-A1 | Quaternary Ammonium Salt Prodrugs | ALKERMES, INC. (US) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178068-A1 | Quaternary Ammonium Salt Prodrugs | SLC1A5, IDH1, ASS1 | DRD2 756/4885DRD3 714/4885HTR1A 1881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.